New therapies for malignant melanoma.
Once malignant melanoma has metastasised, conventional therapy is rarely curative. However, major technological advances have heralded the era of 'new' immunotherapy with agents such as the interferons and interleukin-2. These promising treatment options have not yet been fully evaluated.
Hancock
B
B
D003131:Combined Modality Therapy; D006801:Humans; D007167:Immunotherapy; D007372:Interferons / Q000627:therapeutic use; D007376:Interleukin-2 / Q000627:therapeutic use; D008545:Melanoma / Q000556:secondary / Q000628:therapy*; D012878:Skin Neoplasms / Q000628:therapy*
D007376:Interleukin-2; D007372:Interferons